Corona vaccine brings good news, US company immunizes 5 times

Washington / Berlin, Ta. 21 August 2020, Friday

The new Corona virus, produced by the American company Pfizer and the German company Bioentech, has yielded better results. Earlier, Pfizer released data for the second Corona vaccine last month. During the trial, it was found that the number of side effects in the second vaccine was halved compared to the first vaccine.

Reduction in cases of side effects in volunteers

According to a report published in the Daily Mail, the manufacturers of Corona said that the second vaccine had better results because the second vaccine provided better immunity. Because of this, there has been a reduction in cases of side effects among volunteers.

Antibody levels are higher in vaccinated volunteers

According to data published on medRxiv.org, antibody levels were found to be up to five times (6.X x) in vaccine-administered volunteers compared to patients recovering from corona. William Gruber, Pfizer's senior vice president of vaccine development, said the more the body tolerates the vaccine, the greater the acceptance of the vaccine.

2 samples of the vaccine make good antibodies

However, William Gruber described both BNNT162B1 (B1) and BNT162B2 (B2) as good candidates. But he said we are lucky that B2 is more satisfactory because it also produces better immunity and its reaction is less.

16.7% reduction in side effects

During the trial, it was found that 50 percent of people aged 18 to 55 who administered the B1 vaccine had moderate side effects, while 16.7 percent of people aged 65 to 85 had a reaction. But the side effects of the second vaccine have dropped to 16.7 per cent in people between the ages of 18 and 55, and no side effects in people between the ages of 65 and 85.